Skip to content
10-Q

Quarterly Report

Edwards Lifesciences Corp EW

0001099800-26-000026

← back to feed
Filed
May 6, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · Apr 30, 2026 575.8M sh
Shares Diluted Q1 2026 · Mar 31, 2026 580.7M sh
Shares Diluted Q1 2026 · Mar 31, 2025 587.8M sh
Stock Repurchased Q1 2026 · Mar 31, 2026 $421.8M
Stock Repurchased Q1 2026 · Mar 31, 2025 $258.6M
Capex Q1 2026 · Mar 31, 2026 $64.9M
Capex Q1 2026 · Mar 31, 2025 $56M
Operating Cash Flow Q1 2026 · Mar 31, 2026 $43.8M
Operating Cash Flow Q1 2026 · Mar 31, 2025 $280.4M
Long Term Debt Q1 2026 · Mar 31, 2026 $598.5M
Long Term Debt Q1 2026 · Dec 31, 2025 $598.3M
Short Term Investments Q1 2026 · Mar 31, 2026 $1.23B
Short Term Investments Q1 2026 · Dec 31, 2025 $1.29B
Cash And Equivalents Q1 2026 · Mar 31, 2026 $2.45B
Cash And Equivalents Q1 2026 · Dec 31, 2025 $2.94B
Stockholders Equity Q1 2026 · Mar 31, 2026 $10.33B
Stockholders Equity Q1 2026 · Dec 31, 2025 $10.34B
Current Liabilities Q1 2026 · Mar 31, 2026 $1.41B
Current Liabilities Q1 2026 · Dec 31, 2025 $1.81B
Total Liabilities Q1 2026 · Mar 31, 2026 $2.99B
Total Liabilities Q1 2026 · Dec 31, 2025 $3.36B
Current Assets Q1 2026 · Mar 31, 2026 $6.23B
Current Assets Q1 2026 · Dec 31, 2025 $6.74B
Total Assets Q1 2026 · Mar 31, 2026 $13.32B
Total Assets Q1 2026 · Dec 31, 2025 $13.7B
Eps Diluted Q1 2026 · Mar 31, 2026 $0.66
Eps Diluted Q1 2026 · Mar 31, 2025 $0.61
Eps Basic Q1 2026 · Mar 31, 2026 $0.66
Eps Basic Q1 2026 · Mar 31, 2025 $0.61
Sga Expense Q1 2026 · Mar 31, 2026 $522.2M
Sga Expense Q1 2026 · Mar 31, 2025 $465.7M
Rd Expense Q1 2026 · Mar 31, 2026 $263.3M
Rd Expense Q1 2026 · Mar 31, 2025 $254.6M
Net Income Q1 2026 · Mar 31, 2026 $380.7M
Net Income Q1 2026 · Mar 31, 2025 $358M
Operating Income Q1 2026 · Mar 31, 2026 $477.6M
Operating Income Q1 2026 · Mar 31, 2025 $394.8M
Gross Profit Q1 2026 · Mar 31, 2026 $1.29B
Gross Profit Q1 2026 · Mar 31, 2025 $1.11B
Cost Of Revenue Q1 2026 · Mar 31, 2026 $362.6M
Cost Of Revenue Q1 2026 · Mar 31, 2025 $301.6M
Revenue Q1 2026 · Mar 31, 2026 $1.65B
Revenue Q1 2026 · Mar 31, 2025 $1.41B